...
首页> 外文期刊>Journal of Liquid Chromatography & Related Technologies >GRADIENT HPLC-DAD DETERMINATION OF THE ANTIHYPERTENSIVE MIXTURE OF AMLODIPINE BESYLATE, VALSARTAN, AND HYDROCHLOROTHIAZIDE IN COMBINED PHARMACEUTICAL TABLETS
【24h】

GRADIENT HPLC-DAD DETERMINATION OF THE ANTIHYPERTENSIVE MIXTURE OF AMLODIPINE BESYLATE, VALSARTAN, AND HYDROCHLOROTHIAZIDE IN COMBINED PHARMACEUTICAL TABLETS

机译:梯度HPLC-DAD法测定组合药物片剂中苯磺酸氨地平,缬沙坦和盐酸氟噻嗪的降压药混合物。

获取原文
获取原文并翻译 | 示例
           

摘要

A triple drug combination of amlodipine besylate (AML), valsartan (VAL), and hydrochlothiazide (HCT) was recently approved by the European Medicines Agency and the FDA for the treatment of moderate and severe hypertension. In this work, a simple, rapid, and reliable HPLC-DAD method was described for the simultaneous determination of the three antihypertensives. Chromatographic separation was achieved using Zorbax SB-C8 column with gradient elution of the mobile phase composed of 0.025 M phosphoric acid and acetonitrile. The gradient elution started with 30% (by volume) acetonitrile, ramped up linearly to 70% in 3 min then kept constant for the remainder of the run. The flow rate was 1 mL/min. The multiple wavelength detector was set at 238 nm for measurement of AML and 225 nm for VAL and HCT. Quantification was based on measuring peak areas. The analytes were resolved with retention times 4.2, 4.7, and 6.5 min for HCT, AML, and VAL, respectively. Analytical performance of the proposed procedure was validated with respect to system suitability, linearity, ranges, precision, accuracy, robustness, detection, and quantification limits. The linearity ranges were 5-100, 2.5-200, and 2.5-100 µg/mL for AML, VAL, and HCT, respectively. The validated HPLC method was extended to the analysis of this combination in several laboratory-prepared mixtures of different ratios. Specificity was tested by resolution of the three analytes from several pharmaceutical compounds of various medicinal categories. Finally, Exforge HCT® tablets were assayed using the developed procedure where no interfering peaks were encountered from the tablet additives.View full textDownload full textKeywordsamlodipine besylate, HPLC-DAD, hydrochlorothiazide, pharmaceutical tablets, simultaneous determination, valsartanRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/10826076.2011.597071
机译:最近,欧洲药品管理局和FDA批准了苯磺酸氨氯地平(AML),缬沙坦(VAL)和氢氯噻嗪(HCT)的三联药物组合用于中度和重度高血压的治疗。在这项工作中,描述了一种同时测定三种降压药的简单,快速,可靠的HPLC-DAD方法。使用Zorbax SB-C8色谱柱,用0.025 M磷酸和乙腈组成的流动相进行梯度洗脱,实现了色谱分离。梯度洗脱始于30%(按体积计)乙腈,在3分钟内线性上升至70%,然后在其余运行中保持恒定。流速为1 mL / min。多波长检测器设置为238 nm的AML和225和VAL和HCT的测量。定量基于测量峰面积。被分析物的保留时间分别为HCT,AML和VAL,分别为4.2、4.7和6.5分钟。相对于系统适用性,线性,范围,精度,准确性,鲁棒性,检测和定量限,验证了所提出程序的分析性能。线性范围分别为5-100,2.5-200和2.5-100 µg / mL的AML,VAL和HCT,分别。经过验证的HPLC方法已扩展到分析各种比例的实验室制备混合物中的这种组合。通过解析来自各种药用类别的几种药物化合物中的三种分析物来测试特异性。最终,使用开发的程序对ExforgeHCT®片剂进行了测定,其中没有发现片剂添加剂产生干扰峰。查看全文下载全文关键词泰勒和弗朗西斯在线”,services_compact:“ citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,更多”,发布号:“ ra-4dff56cd6bb1830b”};添加到候选列表链接永久链接http://dx.doi.org/10.1080/10826076.2011.597071

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号